Chitosan oligosaccharide: Biological activities and potential therapeutic applications

被引:410
作者
Muanprasat, Chatchai [1 ,2 ]
Chatsudthipong, Varanuj [1 ]
机构
[1] Mahidol Univ, Fac Sci, Excellent Ctr Drug Discovery, Rama VI Rd, Bangkok 10400, Thailand
[2] Mahidol Univ, Fac Sci, Dept Physiol, Rama VI Rd, Bangkok 10400, Thailand
关键词
Chitosan; Chitosan oligosaccharide; Chitin; Polymers; Drug discovery; MOLECULAR-WEIGHT CHITOSAN; WATER-SOLUBLE CHITOSAN; HIGH-FAT DIET; NF-KAPPA-B; CARDIOVASCULAR-DISEASE RISK; ACE INHIBITORY-ACTIVITY; VEIN ENDOTHELIAL-CELLS; IN-VITRO; NITRIC-OXIDE; LONG-TERM;
D O I
10.1016/j.pharmthera.2016.10.013
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Chitosan oligosaccharide (COS) is an oligomer of beta-(1 -> 4)-linked D-glucosamine. COS can be prepared from the deacetylation and hydrolysis of chitin, which is commonly found in the exoskeletons of arthropods and insects and the cell walls of fungi. COS is water soluble, non-cytotoxic, readily absorbed through the intestine and mainly excreted in the urine. Of particular importance, COS and its derivatives have been demonstrated to possess several biological activities including anti-inflammation, immunostimulation, anti-tumor, anti-obesity, anti hypertension, anti-Alzheimer's disease, tissue regeneration promotion, drug and DNA delivery enhancement, anti-microbial, anti-oxidation and calcium-absorption enhancement. The mechanisms of actions of COS have been found to involve the modulation of several important pathways including the suppression of nuclear factor kappa B (NF-kappa B) and mitogen-activated protein kinases (MAPK) and the activation of AMP-activated protein kinase (AMPK). This review summarizes the current knowledge of the preparation methods, pharmacokinetic profiles, biological activities, potential therapeutic applications and safety profiles of COS and its derivatives. In addition, future research directions are discussed. (C) 2016 Elsevier Inc All rights reserved.
引用
收藏
页码:80 / 97
页数:18
相关论文
共 206 条
[1]
Production of Chitooligosaccharides and Their Potential Applications in Medicine [J].
Aam, Berit B. ;
Heggset, Ellinor B. ;
Norberg, Anne Line ;
Sorlie, Morten ;
Varum, Kjell M. ;
Eijsink, Vincent G. H. .
MARINE DRUGS, 2010, 8 (05) :1482-1517
[2]
Polymer gene delivery: overcoming the obstacles [J].
Aied, Ahmed ;
Greiser, Udo ;
Pandit, Abhay ;
Wang, Wenxin .
DRUG DISCOVERY TODAY, 2013, 18 (21-22) :1090-1098
[3]
Dietary and pharmacological compounds altering intestinal calcium absorption in humans and animals [J].
Areco, Vanessa ;
Angelica Rivoira, Maria ;
Rodriguez, Valeria ;
Maria Marchionatti, Ana ;
Carpentieri, Agata ;
Tolosa de Talamoni, Nori .
NUTRITION RESEARCH REVIEWS, 2015, 28 (02) :83-99
[4]
Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides [J].
Artan, Murat ;
Karadeniz, Fatih ;
Karagozlu, Mustafa Zafer ;
Kim, Moon-Moo ;
Kim, Se-Kwon .
CARBOHYDRATE RESEARCH, 2010, 345 (05) :656-662
[5]
The biology of innate lymphoid cells [J].
Artis, David ;
Spits, Hergen .
NATURE, 2015, 517 (7534) :293-301
[6]
ATKINSON AB, 1979, LANCET, V2, P836
[7]
Chito-Oligosaccharide Inhibits the De-Methylation of a 'CpG' Island within the Leptin (LEP) Promoter during Adipogenesis of 3T3-L1 Cells [J].
Bahar, Bojlul ;
O'Doherty, John V. ;
O'Doherty, Alan M. ;
Sweeney, Torres .
PLOS ONE, 2013, 8 (03)
[8]
Chitooligosaccharide elicits acute inflammatory cytokine response through AP-1 pathway in human intestinal epithelial-like (Caco-2) cells [J].
Bahar, Bojlul ;
O'Doherty, John V. ;
Maher, Sam ;
McMorrow, Jason ;
Sweeney, Torres .
MOLECULAR IMMUNOLOGY, 2012, 51 (3-4) :283-291
[9]
Barroso Aranda Jorge, 2002, J Med, V33, P209
[10]
Nutritional aspects of calcium absorption [J].
Bronner, F ;
Pansu, D .
JOURNAL OF NUTRITION, 1999, 129 (01) :9-12